FTC

Horizon Therapeutics says Amgen deal could close earlier than planned if FTC fails to block it
CNBC
Thu, 05/18/23 - 08:42 pm
Horizon Therapeutics
M&A
Amgen
FTC
Regeneron CEO backs FTC’s attempt to block $28B Amgen-Horizon deal
Medical Marketing and Media
Wed, 05/17/23 - 10:48 pm
Amgen
Horizon Therapeutics
FTC
Regeneron
antitrust
M&A
Leonard Schleifer
Does FTC attempt to block Amgen's Horizon buy spell trouble for Pfizer-Seagen? Not necessarily, analysts say
Fierce Pharma
Wed, 05/17/23 - 11:29 am
FTC
M&A
Amgen
Horizon Therapeutics
Pfizer
Seagen
antitrust
Amgen ‘Remains Committed’ to $27.8B Horizon Acquisition After FTC Challenge
BioSpace
Tue, 05/16/23 - 11:02 pm
Amgen
Horizon Therapeutics
M&A
FTC
FTC sues to block Amgen’s $27.8B deal for Horizon Therapeutics
Medical Marketing and Media
Tue, 05/16/23 - 12:17 pm
Amgen
Horizon Therapeutics
FTC
M&A
Pfizer, Seagen kick off antitrust review of $43B merger. Will FTC get on board?
Fierce Pharma
Mon, 05/15/23 - 11:19 am
Pfizer
Seagen
M&A
antitrust
DOJ
FTC
The FTC put pharma giants on notice for deceptive marketing claims. But does it actually have the authority?
Medical Marketing and Media
Thu, 04/27/23 - 10:44 pm
FTC
pharma marketing
deceptive marketing
JNJ
Pfizer
Sanofi's Provention buyout hit with FTC delay. Will Pfizer's Seagen deal go off as planned?
Fierce Pharma
Tue, 04/11/23 - 11:46 am
M&A
antitrust
FTC
Sanofi
Provention Bio
Pfizer
Seagen
FTC orders Illumina to divest $7.1 billion acquisition of cancer test developer Grail
CNBC
Mon, 04/3/23 - 11:36 am
FTC
Illumina
Grail
competition
M&A
diagnostics
FTC says patent battle over Parkinson's drug could have 'significant implications' for patients
Endpoints
Tue, 03/21/23 - 09:56 pm
FTC
Parkinson's Disease
Apokyn
Supernus Pharmaceuticals
Sage Chemical
patents
In Pfizer-Seagen review, FTC has chance to set new pharma precedent
BioPharma Dive
Tue, 03/14/23 - 06:28 pm
FTC
Pfizer
Seagen
M&A
antitrust
anticompetitive practices
US deal watchdog's bark could be worse than its bite
EP Vantage
Thu, 02/23/23 - 09:58 am
M&A
FTC
FTC's Non-Compete Law Could Propel Rise in Trade Secrets Lawsuits
BioSpace
Wed, 02/8/23 - 10:43 am
FTC
non-compete
trade secrets
legal
Warren keeps pressure on pharma, this time targeting Amgen and Indivior buyouts
Fierce Pharma
Mon, 01/30/23 - 10:41 am
Elizabeth Warren
Senate
FTC
M&A
Amgen
Horizon Therapeutics
Indivior
Opiant Pharmaceuticals
Martin Shkreli runs afoul of FTC for potentially skirting lifetime pharmaceutical industry ban
Fierce Pharma
Sun, 01/22/23 - 12:54 pm
Martin Shkreli
FTC
Druglike
Pharma’s digital marketing in crosshairs, as FTC’s plan to curb ‘commercial surveillance’ gains steam
Medical Marketing and Media
Mon, 11/28/22 - 07:49 pm
FTC
pharma marketing
digital marketing
surveillance marketing
In Jazz case, FTC urges court to delist patent on blockbuster Xyrem
Fierce Pharma
Mon, 11/14/22 - 10:55 am
Jazz Pharma
FTC
Xyrem
narcolepsy
legal
FTC Amicus Brief Challenges Abuse of FDA “Orange Book” Listing Procedures to Block Drug Competition
FTC
Sun, 11/13/22 - 06:56 pm
legal
FTC
Orange Book
Jazz Pharmaceuticals
Avadel Pharma
patents
competition
EU swats down Illumina's $8B Grail acquisition days after FTC lost antitrust case
Endpoints
Tue, 09/6/22 - 10:36 am
Europe
Illumina
Grail
FTC
M&A
Illumina defeats F.T.C. in major antitrust case
NY Times, NY
Thu, 09/1/22 - 07:46 pm
Illumina
FTC
Grail
M&A
antitrust

Pages